Skip to main content
Premium Trial:

Request an Annual Quote

Bioethics Commission Catches Flack over Report

In its newly released report, The Presidential Commission for the Study of Bioethical Issues says that synthetic biology currently poses few risks and recommends that investigators in the field self-regulate their research, according to the New York Times. "Here's something significant in science, but there's no cause for fear and dread about what is going to happen immediately next," says commission chair Amy Gutmann about synthetic biology. In addition, Craig Venter, who discussed his synthetic genomics research with the panel, tells the Times he considers the group's recommendations "wise, warranted and restrained, which will help to ensure that this young field of research will flourish in a positive manner."

However, not everyone is pleased with the commission's stance. "More than 50 environmental groups from around the world signed an open letter to federal officials calling for a moratorium on the release and commercial use of synthetic organisms until the risks are understood and regulations developed," the Times adds. Among other things, the letter warns that "self-regulation amounts to no regulation."

While its critics are vociferous — Rutgers University's Richard Ebright calls the commission's recommendations "very thin gruel," and says that the report "suggests no substantive oversight and that [it] is fundamentally empty," in a Nature article — Jonathon Moreno at Science Progress says that the commission struck "the right balance" in weighing the risks and benefits of the emerging field.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.